Release Date: 13/02/14 18:43 Summary: Suspension - Close of Trade 17 February 2014 Price Sensitive: Yes Download Document 21.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%